文献速递类风湿关节炎

关节相关肽自身抗体与症状前血清阴性个体类风湿关节炎发病相关

Autoantibodies to Joint-Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals.
PubMed 文献 · Arthritis Rheumatol · 2026-04-17

研究在三个队列中检测针对关节相关肽的IgG自身抗体,包括症状前后来发展为RA者518例、其中241例RA诊断时、匹配人群对照530例及OA患者287例。SeNe检测在抗CCP和RF阴性个体中识别出13%在2.5年内出现症状者,区分RA与OA的特异性为97%(95%CI 95%-99%);改进版SeNe 2.0在抗CCP和RF阴性症状前个体中识别出16%,对人群对照特异性98%。这些新型生物标志物可识别症状前血清阴性高危个体并支持个性化预防试验招募。

要点

  • SeNe检测在抗CCP和RF阴性个体中识别13%在2.5年内出现症状者,RA vs OA特异性97%。
  • SeNe 2.0在抗CCP和RF阴性症状前个体中识别16%,对人群对照特异性98%。
  • 自身抗体谱揭示三个症状前亚组,提示早期免疫异质性。

核心结论

  • 新型生物标志物可识别症状前血清阴性RA高危个体,并高特异性区分早期血清阴性RA与OA。

研究设计与样本

  • 分析三个队列:症状前后来发展为RA者518例、其中241例RA诊断时、匹配人群对照530例及OA患者287例。
  • 采用珠基多重流式免疫分析检测针对关节相关肽的IgG自身抗体,主成分分析识别亚组,单变量回归评估SeNe检测性能,多变量逻辑回归识别最具区分力的自身抗体。

主要发现

  • 自身抗体谱揭示三个 distinct 症状前亚组,提示早期免疫异质性。
  • SeNe检测与抗CCP和RF阴性个体中13%在2.5年内出现症状相关。
  • SeNe检测区分RA与OA的特异性为97%(95%CI 95%-99%)。
  • SeNe 2.0在抗CCP和RF阴性症状前个体中识别16%,对人群对照特异性98%。
  • 多变量模型中SeNe 2.0五种自身抗体中有两种与症状前状态相关,包括RF和抗CCP。

关键数值与推荐

  • SeNe检测:抗CCP和RF阴性个体中13%在2.5年内出现症状,RA vs OA特异性97%(95%CI 95%-99%)。
  • SeNe 2.0:抗CCP和RF阴性症状前个体中识别16%,对人群对照特异性98%。

临床怎么用

  • 可考虑用关节相关肽自身抗体检测识别抗CCP和RF阴性但RA高风险的症状前个体,以支持个性化预防试验招募。
  • 在早期血清阴性RA与OA鉴别困难时,该检测高特异性有助于区分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify autoantibodies in presymptomatic individuals that associate with the onset of rheumatoid arthritis (RA) and to distinguish early RA from osteoarthritis (OA), particularly in individuals lacking classic RA serologic markers. METHODS: We analyzed serum and plasma from three cohorts: presymptomatic individuals who later developed RA (n = 518), a subset of these at RA diagnosis (n = 241), matched population controls (n = 530), and patients with OA (n = 287). Bead-based multiplex flow immunoassay detected IgG autoantibodies against joint-related peptides relevant in arthritis models. Principal component analysis was used to identify subgroups and univariable regression analyses to characterize the performance of autoantibodies with significance for patients with RA negative for anti-cyclic citrullinated peptide (anti-CCP) and rheumatoid factor (RF), that is, the seronegative RA diagnosis (SeNe) test. Multivariable logistic regression identified autoantibodies with the strongest discriminative power between cases and controls. RESULTS: Autoantibody profiles revealed three distinct presymptomatic subgroups, suggesting early immune heterogeneity. The SeNe test was associated with symptom onset within 2.5 years in 13% of anti-CCP and RF-negative individuals. Specificity for RA versus OA was 97% (95% confidence interval, 95%-99%). An improved version (SeNe 2.0) identified 16% of anti-CCP and RF-negative presymptomatic individuals with 98% specificity versus population controls. Two of five SeNe 2.0 autoantibodies were associated with the presymptomatic state in the multivariable model, including RF and anti-CCP. CONCLUSION: These novel biomarkers can identify presymptomatic, seronegative individuals at high risk of RA onset and support their recruitment into trials for personalized prevention. Additionally, they distinguish early seronegative RA from OA with high specificity.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Sareila O, Johansson L, Lundquist A, et al. Autoantibodies to Joint-Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals. Arthritis Rheumatol. 2026. PMID: 41994938. doi:10.1002/art.70184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。